CCL18 and pancreatic neoplasm: In pancreatic cancer, TAM-M2 cells have been found to enhance aerobic glycolysis in pancreatic cancer cells, thereby promoting tumor invasion and metastasis via the secretion of the chemokine CCL18, which interacts with its receptor, PITPNM3 [186].